Recent Finacing
Recent Raise
Velicept Therapeutics is a clinical-stage pharmaceutical company developing solabegron, a selective beta-3 adrenoceptor agonist for overactive bladder and IBS, conducting Phase 2b VEL2001 once-daily and VEL2002 BID trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
